Geoffrey S. Martha is the CEO of Medtronic plc, a top player in medical technology, since April 2020. He previously held the position of President and led the Restorative Therapies Group. His journey at Medtronic started in 2011, and he's...

Geoffrey S. Martha is the CEO of Medtronic plc, a top player in medical technology, since April 2020. He previously held the position of President and led the Restorative Therapies Group. His journey at Medtronic started in 2011, and he's known for strong business development skills, having also worked at GE Healthcare. In 2023, Geoffrey received a total compensation of around $2.15 million, with a large part coming from performance-based bonuses tied to the company's revenue and cash flow achievements. His experience in guiding Medtronic through strategic developments is noteworthy. As of 2024, he holds approximately 184,914 shares of Medtronic stock, alongside various stock options and performance shares. An interesting aspect of his career is the significant equity grant he received after becoming President, reflecting the Board's trust in his leadership.